Aminosalicylates are often used as first-line therapy to reduce inflammation in patients with ulcerative colitis.

The team tested an aminosalicylic derivative for its ability to inhibit drug-resistant tuberculosis.

The research team isolated an aminosalicylate from the reaction mixture and characterized its antibacterial properties.

During the lecture, the professor highlighted how aminosalicylic acid can act as both an intermediate in synthesis and a point of mechanistic interest.

Recent studies show that aminosalicylic acids can inhibit the growth of certain antibiotic-resistant bacteria.